silver has been researched along with deferasirox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abolhasani, J; Hassanzadeh, J; Naderali, R | 1 |
| Adel, RM; Amer, AS; Darwish, AS; Lotfy, RA | 1 |
2 other study(ies) available for silver and deferasirox
| Article | Year |
|---|---|
Ag Nanoparticles-enhanced Fluorescence of Terbium-Deferasirox Complexes for the Highly Sensitive Determination of Deferasirox.
Topics: Benzoates; Deferasirox; Fluorescence; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Molecular Structure; Particle Size; Silver; Spectrometry, Fluorescence; Tablets; Terbium; Triazoles | 2016 |
Destructive effect of iron overload in brain tissue of albino rats: Ameliorative role of silver immobilized organo-modified casein nanocomposite as co-treating agent with Deferasirox.
Topics: Animals; Antioxidants; Brain; Caseins; Deferasirox; Follicle Stimulating Hormone; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Metal Nanoparticles; Nanocomposites; Pharmaceutical Preparations; Rats; Silver | 2021 |